Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomised placebo-controlled Phase III multicentre trial: low-dose intravenous immunoglobulin treatment for long-standing complex regional pain syndrome (LIPS trial).
Goebel A, Bisla J, Carganillo R, Cole C, Frank B, Gupta R, James M, Kelly J, McCabe C, Milligan H, Murphy C, Padfield N, Phillips C, Poole H, Saunders M, Serpell M, Shenker N, Shoukrey K, Wyatt L, Ambler G. Goebel A, et al. Among authors: bisla j. Southampton (UK): NIHR Journals Library; 2017 Nov. Southampton (UK): NIHR Journals Library; 2017 Nov. PMID: 29144634 Free Books & Documents. Review.
Low-Dose Intravenous Immunoglobulin Treatment for Long-Standing Complex Regional Pain Syndrome: A Randomized Trial.
Goebel A, Bisla J, Carganillo R, Frank B, Gupta R, Kelly J, McCabe C, Murphy C, Padfield N, Phillips C, Sanders M, Serpell M, Shenker N, Shoukrey K, Wyatt L, Ambler G. Goebel A, et al. Among authors: bisla j. Ann Intern Med. 2017 Oct 3;167(7):476-483. doi: 10.7326/M17-0509. Epub 2017 Sep 12. Ann Intern Med. 2017. PMID: 28973211 Free article. Clinical Trial.
Successful and unsuccessful recruitment and retainment strategies in a UK multicentre drug trial for a rare chronic pain condition which performed above target.
Bisla J, Ambler G, Frank B, Gulati S, Hocken P, James M, Kelly J, Keshet-Price J, McCabe C, McGylnn D, Padfield N, Pang D, Pout G, Sanders M, Serpell M, Shenker N, Shoukrey K, Wesley S, Weston M, White-Alao B, Wyatt L, Murphy C, Goebel A. Bisla J, et al. Br J Pain. 2020 Aug;14(3):171-179. doi: 10.1177/2049463719893399. Epub 2019 Dec 24. Br J Pain. 2020. PMID: 32922778 Free PMC article.
Extended-release pharmacotherapy for opioid use disorder (EXPO): protocol for an open-label randomised controlled trial of the effectiveness and cost-effectiveness of injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone.
Marsden J, Kelleher M, Hoare Z, Hughes D, Bisla J, Cape A, Cowden F, Day E, Dewhurst J, Evans R, Hearn A, Kelly J, Lowry N, McCusker M, Murphy C, Murray R, Myton T, Quarshie S, Scott G, Turner S, Vanderwaal R, Wareham A, Gilvarry E, Mitcheson L. Marsden J, et al. Among authors: bisla j. Trials. 2022 Aug 19;23(1):697. doi: 10.1186/s13063-022-06595-0. Trials. 2022. PMID: 35986418 Free PMC article.
Superiority and cost-effectiveness of monthly extended-release buprenorphine versus daily standard of care medication: a pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trial.
Marsden J, Kelleher M, Gilvarry E, Mitcheson L, Bisla J, Cape A, Cowden F, Day E, Dewhurst J, Evans R, Hardy W, Hearn A, Kelly J, Lowry N, McCusker M, Murphy C, Murray R, Myton T, Quarshie S, Vanderwaal R, Wareham A, Hughes D, Hoare Z. Marsden J, et al. Among authors: bisla j. EClinicalMedicine. 2023 Nov 17;66:102311. doi: 10.1016/j.eclinm.2023.102311. eCollection 2023 Dec. EClinicalMedicine. 2023. PMID: 38045803 Free PMC article.
16 results